Beyond Blood Glucose: Managing High Triglycerides and Heart Disease Risk When Living with Diabetes

Why It Matters

Elevated triglycerides significantly increase cardiovascular mortality in people with diabetes, making comprehensive risk management essential for improving outcomes and reducing health‑care costs.

Key Takeaways

• Webinar teaches triglyceride-lowering diet and exercise plans.
• Experts review latest lipid‑lowering medications for diabetics.
• Discuss cardiovascular risk assessment tools beyond HbA1c.
• Free registration for clinicians, patients, and caregivers.
• ADA encourages donations to fund diabetes research.

Pulse Analysis

High triglyceride levels are a common but often overlooked companion to elevated blood glucose in diabetes. While HbA1c remains the headline metric for glycemic control, research shows that triglyceride‑rich lipoproteins drive atherosclerotic plaque formation, contributing to the leading cause of death among diabetics—heart disease. The American Diabetes Association (ADA) highlights this gap by dedicating a webinar to the “beyond glucose” approach, underscoring the need for clinicians and patients to monitor lipid panels regularly and act on abnormal readings.

Effective triglyceride management blends lifestyle modification with evidence‑based pharmacotherapy. Experts will outline dietary patterns low in refined carbohydrates and saturated fats, emphasizing omega‑3 fatty acids, fiber, and regular aerobic activity as first‑line tools. For patients who do not achieve targets through diet alone, the session will review FDA‑approved agents such as icosapent ethyl, fibrates, and high‑intensity statins, discussing their safety profile in the context of diabetes. The webinar also covers emerging risk‑assessment algorithms that integrate non‑fasting triglyceride values, coronary calcium scoring, and inflammatory markers, offering a more nuanced picture than HbA1c alone.

Education is a critical lever for translating guidelines into practice. By offering a free, accessible platform, the ADA empowers a broad audience—endocrinologists, primary‑care physicians, dietitians, and patients—to stay current on lipid‑management strategies that can curb cardiovascular events. The event also serves as a fundraising touchpoint, inviting contributions that fuel ongoing research into novel therapies and patient‑centered resources. Participants leave with actionable insights, a clearer risk‑reduction roadmap, and a reminder that tackling triglycerides is as vital as controlling glucose for long‑term health.